KP Biomedical Engineering - Issue #8

KP Biomedical Engineering - Issue #8



-Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging CHICAGO--(BUSINESS WIRE)

--At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) announced the release of the OptoVolt™ module to further expand the advanced neuroscience research capabilities on Bruker’s Ultima multiphoton microscope platform. OptoVolt accelerates imaging speeds to beyond 1000 frames per second for the capture of millisecond dynamics of cell-to-cell neural communication.


-BlinkRx is Now Offering neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis NEW YORK--(BUSINESS WIRE)

--BlinkRx, the world’s most advanced patient access platform for branded medications, is excited to announce a new partnership with ARS Pharmaceuticals to offer neffy®, the needle-free epinephrine nasal spray, now available on its platform. neffy is the first and only needle-free treatment for severe allergic reactions, including life-threatening anaphylaxis for children and adults who weigh 30kgs (66lbs.)


-Global Quantum Sensors Market Report 2025-2035: Company Profiles of Airbus, Atomionics, Chipiron, ColdQuanta, EuQlid, Infleqtion, Mesa Quantum, MuQuans, NVision, Q-CTRL, Qnami, Quantum Systems & More - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "Global Market for Quantum Sensors 2025-2035" report has been added to ResearchAndMarkets.com's offering. Quantum sensing is an emerging technology that allows for extremely precise measurements at the atomic level. It offers advantages over traditional sensors in terms of accuracy, consistency, and measurement frequency.


-GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe CHICAGO--(BUSINESS WIRE)

--GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The €25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups.


-Cutera® to Announce Third Quarter Results on November 7, 2024 BRISBANE, Calif.--(BUSINESS WIRE)

--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced that it will report financial results for the third quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024. The Company’s management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day.


-AccurKardia Receives FDA Breakthrough Device Designation for First-of-its-Kind Aortic Valve Stenosis ECG-based AI Screening Software NEW YORK--(BUSINESS WIRE)

--AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based AI screening software has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).


-AtriCure to Announce Third Quarter 2024 Financial Results MASON, Ohio--(BUSINESS WIRE)

--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2024 financial results on Tuesday, October 29, 2024.


-GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns STAMFORD, Conn.--(BUSINESS WIRE)

--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced it has provided genomic newborn screenings (gNBS) for more than 14,000 infants through its participation in groundbreaking research studies which aim to explore the clinical utility and implementation of utilizing genome sequencing to expand standard newborn screening (NBS).


-NTT DATA Collaborates with Leading Academic Medical System on New Model of In-Home Care PLANO, Texas--(BUSINESS WIRE)

--NTT DATA, a global leader in healthcare IT, and Duke Health, a world-class academic and healthcare system, are collaborating to create a highly interactive and technologically advanced model for augmented home care delivery. This new home-care model will integrate multiple technologies, including a GenAI-driven virtual agent from Ellipsis Health, automation, device interoperability, remote patient monitoring and a patient app and portal.


-QuidelOrtho Announces New R&D Executive Leader SAN DIEGO--(BUSINESS WIRE)

--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the appointment of Jonathan Siegrist, PhD, as its new Executive Vice President of Research and Development (R&D) and Chief Technology Officer (CTO), effective as of October 7, 2024. Siegrist brings a wealth of industry expertise and leadership experience with over 15 years in molecular diagnostics, microfluidic platforms, and biomedical engineering.


-Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years NEW YORK--(BUSINESS WIRE)

--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced that its Ambulnz subsidiary has renewed its contract with Bayhealth – central and southern Delaware’s largest healthcare system – for an additional three-year term. This extension is a testament to Ambulnz’s proven success supporting Bayhealth with timely, dependable non-emergency transportation services.


-Johnson & Johnson Completes Acquisition of V-Wave NEW BRUNSWICK, N.J.--(BUSINESS WIRE)

--Johnson & Johnson1 (NYSE: JNJ) announced it has successfully completed the acquisition of V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. V-Wave will operate as part of Johnson & Johnson MedTech.


-GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging CHICAGO--(BUSINESS WIRE)

--GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which could help lead to quicker diagnosis and treatment for patients. The collaboration is intended to offer health care providers an AI-enabled platform with a catalogue of third-party AI applications.


-Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing (TE-WGS) Outperforms Standard Panel Sequencing SAN DIEGO--(BUSINESS WIRE)

--Inocras, an industry leader in whole genome sequencing and bioinformatics, released a new study highlighting the clinical validation of its CancerVision Target-Enhanced Whole-Genome Sequencing (TE-WGS). In a head-to-head comparison with Ilumina’s widely-used TSO500, Inocras demonstrated TE-WGS’s ability to match the industry standard for biomarker detection in oncology, while also offering additional insights that enhance clinical understanding.


-Forcura Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance JACKSONVILLE, Fla.--(BUSINESS WIRE)

--Forcura, a healthcare workflow management company, announced its entire technology platform, inclusive of the following components, has once again earned certified status by HITRUST for information security: MyForcura Forcura IQ Forcura Circle Forcura Analytics HITRUST r2 Certification demonstrates that Forcura’s entire technology platform has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk.


-KAGA FEI Develops Ultra-small Bluetooth Low Energy Module Compatible with Bluetooth 6.0 YOKOHAMA, Japan--(BUSINESS WIRE)

--KAGA FEI Co., Ltd., a global provider of leading short distance wireless modules, announced the ES4L15BA1 Bluetooth Low Energy module. The module has a built-in antenna and has obtained various certifications.


-ASEAN Medical Diagnostics Market Report 2024, Featuring Profiles of Bangkok Dusit Medical Services, IHH Healthcare, Pathology Asia, PT Diagnos Laboratorium, PT Prodia Widyahusada & Raffles Medical - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "ASEAN Medical Diagnostics Market (Singapore, Malaysia, Indonesia, Thailand & Vietnam): Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The ASEAN medical diagnostics market is anticipated to reach US$18.42 billion in 2028, witnessing growth at a CAGR of 12.60%, over the period 2024-2028.


-VISIE™ Inc. Announces Continuous Anatomic Auto Tracking (CAAT) for Robotic-Assisted Total Knee Arthroplasty AUSTIN, Texas--(BUSINESS WIRE)

--VISIE Inc., formerly known as Advanced Scanners, announces it has successfully demonstrated Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) in its Austin, TX headquarters. Continuous Anatomic Auto Tracking (CAAT) CAAT is a proprietary, highly promising technological leap that gives the power of vision to surgical robotic and navigation systems designed for orthopedic, neuro, cranial, and spine surgery.


-Mount Sinai Installs Visium Fixtures Using State of the Art Far-UVC Technology in New Clinic NEW YORK--(BUSINESS WIRE)

--Lit Thinking, a premier Far-UVC technology company, is excited to announce Mount Sinai has installed ten Visium fixtures in their newly constructed, state-of-the-art Cohen Center for Recovery from Complex Chronic Illnesses (CoRE). Visium is a UL-certified Far-UVC fixture that continuously inactivates airborne pathogens using the transformative power of human-safe Far-UVC energy.


-Surgical Stapling Devices Market Analysis, Trends and Forecasts, 2023-2024 & 2029: Key Players Target Emerging Markets with New Product Launches and Approvals to Expand - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "Global Surgical Stapling Devices Market: Analysis By Type, By Product, By Application, By Region Size and Trends and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global surgical stapling devices market was valued at US$5.23 billion in 2023. The market value is expected to reach US$8.32 billion by 2029. The market is expected to grow at a CAGR of approx. 8% during the forecasted period of 2024-2029.


-Single-cell Technologies Research Report 2023-2024 & 2029 10x Genomics, Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, Illumina, Merck, Promega, Qiagen, & Thermo Fisher Scientific - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "Single-cell Technologies Market Report" has been added to ResearchAndMarkets.com's offering. The global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a compound annual growth rate (CAGR) of 17.1% from 2024 through 2029. The report offers comprehensive insights into the global single-cell technologies market.


-Transverse Medical Appoints Former Boston Scientific EVP and Global Chief Medical Officer, Professor Ian T. Meredith, to Board of Directors DENVER--(BUSINESS WIRE)

--Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device, is pleased to announce the appointment of Ian T. Meredith, MD to the Board of Directors. Professor Meredith brings over 35 years of experience and global leadership in cardiology coupled with successful clinical trials and device commercialization of multiple interventional devices.


-Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens VAUGHAN, Ontario--(BUSINESS WIRE)

--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced that the U.S. Food and Drug Administration has approved the enVista® Envy™ full range of vision intraocular lens (IOL), which offers a continuous range of vision with excellent dysphotopsia tolerance on the widely used enVista IOL platform.


-Haag-Streit Offers “Sneak Preview” of the New METIS Ophthalmic Microscope System at AAO 2024 CHICAGO--(BUSINESS WIRE)

--Haag-Streit, a global leader in ophthalmic medical devices, is proud to introduce METIS, its cutting-edge ophthalmic microscope system, at the upcoming American Academy of Ophthalmology (AAO) 2024 meeting in Chicago. This sneak preview marks the first time METIS will be showcased in America, offering ophthalmic surgeons an exclusive look at this revolutionary technology.


-ZOLL Announces Closing of Acquisition of Select Vyaire Ventilator Product Lines CHELMSFORD, Mass.--(BUSINESS WIRE)

--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that it successfully completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business. With the acquisition complete, ZOLL will immediately make available to customers the bellavista®, fabian®*, LTV®, and 3100 HFOV product lines alongside ZOLL’s other respiratory care offerings.


-FDA Grants Clearance for SPECTRALIS Flex Module, Expanding Access to Advanced Multimodal Ophthalmic Imaging for Underserved Patients FRANKLIN, Mass.--(BUSINESS WIRE)

--Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of the SPECTRALIS® Flex Module. This innovative, multimodal, diagnostic imaging-only platform is uniquely designed for imaging the posterior segment of pediatric and adult patients in a supine position.


-Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 HERCULES, Calif.--(BUSINESS WIRE)

--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2024 on Wednesday, October 30, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.


To view or add a comment, sign in

More articles by Kaan Pazarkoylu

  • KP Biomedical Engineering - Issue #19

    KP Biomedical Engineering - Issue #19

    -Bausch + Lomb to Participate in the 43rd Annual J.P.

  • KP Biomedical Engineering - Issue #18

    KP Biomedical Engineering - Issue #18

    -XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund MILAN--(BUSINESS WIRE) --XGEN Venture, a…

  • KP Biomedical Engineering - Issue #17

    KP Biomedical Engineering - Issue #17

    -Gibson Area Hospital and Health Services Kicks off “Project One” with MEDITECH Expanse CANTON, Mass.--(BUSINESS WIRE)…

  • KP Biomedical Engineering - Issue #16

    KP Biomedical Engineering - Issue #16

    -United States Diabetes Device Market Forecast Report and Company Analysis 2024 DUBLIN--(BUSINESS WIRE) --The "United…

  • KP Biomedical Engineering - Issue #15

    KP Biomedical Engineering - Issue #15

    -Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program NATICK, Mass.--(BUSINESS WIRE)…

  • KP Biomedical Engineering - Issue #14

    KP Biomedical Engineering - Issue #14

    -Aesthetic Industry Leader Rob Hubert Announced as Chief Revenue Officer for Lynch Regenerative Medicine FRANKLIN…

  • KP Biomedical Engineering - Issue #12

    KP Biomedical Engineering - Issue #12

    -CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)…

  • KP Biomedical Engineering - Issue #11

    KP Biomedical Engineering - Issue #11

    -AtriCure to Participate in the UBS Global Healthcare Conference MASON, Ohio--(BUSINESS WIRE) --AtriCure, Inc. (Nasdaq:…

  • KP Biomedical Engineering - Issue #10

    KP Biomedical Engineering - Issue #10

    -Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series SANTA CLARA, Calif.--(BUSINESS WIRE)…

  • KP Biomedical Engineering - Issue #9

    KP Biomedical Engineering - Issue #9

    -NSF Celebrates 80 Years of Improving Human and Planet Health BANGKOK--(BUSINESS WIRE) --NSF, a leading global public…

Insights from the community

Others also viewed

Explore topics